Further large-scale studies on morepatients with COVID-19 disease and a controlled sample collectionwith tissues from patients with various neurological diseases areurgently needed to gain a complete understanding of the underlyingmechanisms of ACE2 expression in a diseased brain and its role inCOVID-19-related neurological symptoms. Here, ACE2 is linked to nervous system disorder.